137 related articles for article (PubMed ID: 38378288)
21. A nationwide survey of opsoclonus-myoclonus syndrome in Japanese children.
Hasegawa S; Matsushige T; Kajimoto M; Inoue H; Momonaka H; Oka M; Ohga S; Ichiyama T;
Brain Dev; 2015 Aug; 37(7):656-60. PubMed ID: 25454391
[TBL] [Abstract][Full Text] [Related]
22. Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series.
Olbert E; Alhani N; Struhal W
Wien Med Wochenschr; 2024 Feb; 174(1-2):30-34. PubMed ID: 37523107
[TBL] [Abstract][Full Text] [Related]
23. Benign paraspinal ganglioneuroma with paraneoplastic opsoclonus myoclonus syndrome.
Prabaharan H; Chandrasekaran S; Shetty N; Nayak K P
BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38417946
[TBL] [Abstract][Full Text] [Related]
24. Pediatric opsoclonus-myoclonus-ataxia syndrome: Experience from a tertiary care university hospital.
Huddar A; Bindu PS; Nagappa M; Bharath RD; Sinha S; Mathuranath PS; Taly AB
Neurol India; 2018; 66(5):1332-1337. PubMed ID: 30232999
[TBL] [Abstract][Full Text] [Related]
25. Opsoclonus-Myoclonus Syndrome: A New Era of Improved Prognosis?
Galstyan A; Wilbur C; Selby K; Hukin J
Pediatr Neurol; 2017 Jul; 72():65-69. PubMed ID: 28479124
[TBL] [Abstract][Full Text] [Related]
26. Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma.
Koh PS; Raffensperger JG; Berry S; Larsen MB; Johnstone HS; Chou P; Luck SR; Hammer M; Cohn SL
J Pediatr; 1994 Nov; 125(5 Pt 1):712-6. PubMed ID: 7525913
[TBL] [Abstract][Full Text] [Related]
27. [Paraneoplastic neurological syndrome in 12 children].
Xiao J; Liu LY; Wu Y; Han TL; Wang X
Zhonghua Er Ke Za Zhi; 2012 Aug; 50(8):598-600. PubMed ID: 23158737
[TBL] [Abstract][Full Text] [Related]
28. [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].
Urman G; Leivi M; Chamorro N; García B; Callea A; Grosman A
Arch Argent Pediatr; 2019 Dec; 117(6):e651-e654. PubMed ID: 31758904
[TBL] [Abstract][Full Text] [Related]
29. [Opsoclonus myoclonus ataxia syndrome in Israel].
Blumkin L; Lerman-Sagie T
Harefuah; 2010 Jan; 149(1):24-8, 63. PubMed ID: 20422836
[TBL] [Abstract][Full Text] [Related]
30. Polyclonal lymphoid expansion drives paraneoplastic autoimmunity in neuroblastoma.
Rosenberg MI; Greenstein E; Buchkovich M; Peres A; Santoni-Rugiu E; Yang L; Mikl M; Vaksman Z; Gibbs DL; Reshef D; Salovin A; Irwin MS; Naranjo A; Ulitsky I; de Alarcon PA; Matthay KK; Weigman V; Yaari G; Panzer JA; Friedman N; Maris JM
Cell Rep; 2023 Aug; 42(8):112879. PubMed ID: 37537844
[TBL] [Abstract][Full Text] [Related]
31. Opsoclonus Myoclonus Ataxia Syndrome Due to SARS-CoV-2.
Finsterer J; Scorza FA
Neuroophthalmology; 2023; 47(1):1-6. PubMed ID: 36798867
[TBL] [Abstract][Full Text] [Related]
32. Rituximab treatment for relapsed opsoclonus-myoclonus syndrome.
Toyoshima D; Morisada N; Takami Y; Kidokoro H; Nishiyama M; Nakagawa T; Ninchoji T; Nozu K; Takeshima Y; Takada S; Nishio H; Iijima K
Brain Dev; 2016 Mar; 38(3):346-9. PubMed ID: 26375512
[TBL] [Abstract][Full Text] [Related]
33. Neuroblastic Tumor Recurrence Associated With Opsoclonus Myoclonus Ataxia Syndrome Relapse a Decade After Initial Resection and Treatments.
Bacchus MK; Anderson DS; Berko ER; States LJ; Bagatell R; Hopkins SE; Batra V
J Pediatr Hematol Oncol; 2023 Apr; 45(3):152-154. PubMed ID: 36897628
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic plasma exchange for a case of refractory opsoclonus myoclonus ataxia syndrome.
Greensher JE; Louie J; Fish JD
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28926689
[TBL] [Abstract][Full Text] [Related]
35. Opsoclonus-myoclonus Syndrome with Neuroblastoma in Children and their Anaesthetic Management.
Gupta A; Kundal R; Pandey M
J Coll Physicians Surg Pak; 2022 Aug; 32(8):1086-1088. PubMed ID: 35932142
[TBL] [Abstract][Full Text] [Related]
36. Opsoclonus-Myoclonus Syndrome, Neuroblastoma, and Insulin-Dependent Diabetes Mellitus in a Child: A Unique Patient.
Ghia T; Kanhangad M; Alessandri AJ; Price G; Gera P; Nagarajan L
Pediatr Neurol; 2016 Feb; 55():68-70. PubMed ID: 26778146
[TBL] [Abstract][Full Text] [Related]
37. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
[TBL] [Abstract][Full Text] [Related]
38. Infection-Associated Opsoclonus: A Retrospective Case Record Analysis and Review of Literature.
Saini L; Dhawan SR; Madaan P; Suthar R; Saini AG; Sahu JK; Sankhyan N
J Child Neurol; 2020 Jun; 35(7):480-484. PubMed ID: 32216501
[TBL] [Abstract][Full Text] [Related]
39. Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: a report from the Pediatric Oncology Group.
Russo C; Cohn SL; Petruzzi MJ; de Alarcon PA
Med Pediatr Oncol; 1997 Apr; 28(4):284-8. PubMed ID: 9078325
[TBL] [Abstract][Full Text] [Related]
40. Childhood opsoclonus-myoclonus syndrome: A case series from Tunisia.
Ben Achour N; Mrabet S; Rebai I; Abid I; Benrhouma H; Klaa H; Rouissi A; Kraoua I; Ben Youssef Turki I
Brain Dev; 2017 Oct; 39(9):751-755. PubMed ID: 28549713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
